Sichuan Kelun-Biotech Biopharmaceutical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Junyou Ge
Chief executive officer
CN¥17.9m
Total compensation
| CEO salary percentage | 14.3% |
| CEO tenure | 3.8yrs |
| CEO ownership | n/a |
| Management average tenure | 3.2yrs |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Aug 21
We Think Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) Can Easily Afford To Drive Business Growth
Jun 14Analysts Have Lowered Expectations For Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990) After Its Latest Results
Mar 27An Intrinsic Calculation For Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990) Suggests It's 45% Undervalued
Jan 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥187m |
| Mar 31 2024 | n/a | n/a | -CN¥354m |
| Dec 31 2023 | CN¥18m | CN¥3m | -CN¥522m |
| Sep 30 2023 | n/a | n/a | -CN¥427m |
| Jun 30 2023 | n/a | n/a | -CN¥333m |
| Mar 31 2023 | n/a | n/a | -CN¥440m |
| Dec 31 2022 | CN¥3m | CN¥2m | -CN¥548m |
Compensation vs Market: Junyou's total compensation ($USD2.48M) is above average for companies of similar size in the Hong Kong market ($USD488.63K).
Compensation vs Earnings: Junyou's compensation has increased whilst the company is unprofitable.
CEO
Junyou Ge (52 yo)
3.8yrs
Tenure
CN¥17,918,000
Compensation
Dr. Junyou Ge serves as an Executive Director of Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. since February 15, 2023 and its Chief Operation Officer since February 2021; General Manager since March 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.8yrs | CN¥17.92m | no data | |
| CFO & Joint Company Secretary | 2.3yrs | no data | no data | |
| Deputy GM | 1.5yrs | no data | no data | |
| Deputy GM | 3.9yrs | no data | no data | |
| Deputy GM and Chief Scientific Officer of Biologics’ Research & Development | 3.3yrs | no data | no data | |
| Deputy GM & Chief Medical Officer | 3.2yrs | no data | no data | |
| Joint Company Secretary | 1.8yrs | no data | no data |
3.2yrs
Average Tenure
52yo
Average Age
Experienced Management: 6990's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.8yrs | CN¥17.92m | no data | |
| Independent Non-Executive Director | 1.8yrs | CN¥142.00k | no data | |
| Independent Non-Executive Director | 1.8yrs | CN¥142.00k | no data | |
| Non-Executive Director | 8yrs | no data | no data | |
| Non-Executive Director | 3.8yrs | CN¥1.46m | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Non Executive Director | 2.8yrs | no data | no data | |
| Non-Executive Director | 2.3yrs | no data | no data | |
| Independent Non-Executive Director | 1.8yrs | CN¥142.00k | no data | |
| Non-Executive Chairman of the Board | 8yrs | no data | no data | |
| Independent Non-Executive Director | 1.8yrs | CN¥142.00k | no data | |
| Chairperson of the Supervisory Committee | 2.8yrs | no data | no data |
2.5yrs
Average Tenure
48.5yo
Average Age
Experienced Board: 6990's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.